HOME >> BIOLOGY >> NEWS
Pittsburgh NMR Center for Biomedical Research at Carnegie Mellon

The Pittsburgh NMR Center for Biomedical Research has received a five-year, $6.7 million grant from the National Institute of Biomedical Imaging and Bioengineering to pursue innovative work in applying nuclear magnetic resonance (NMR) to biomedical sciences.

The Pittsburgh NMR Center for Biomedical Research is a joint endeavor of Carnegie Mellon University and the University of Pittsburgh and is administered through the MPC Corporation. "We are very pleased to receive this grant, which will help us continue to make major contributions to the rapidly growing field of NMR in biology and medicine," said Chien Ho, director of the center and professor of Biological Sciences at Carnegie Mellon. Funds will allow investigators to pursue research in five technological research and development projects in magnetic resonance imaging (MRI), including:

  • Non-Invasive Detection of Allograft Rejection Using MRI. Organ transplantation is the preferred treatment for patients with end-stage organ failure; however, transplanted organs often fail when a patient's immune system rejects the new implant. Early diagnosis and treatment of organ rejection is critical. Center investigators are developing novel, non-invasive MRI-based methods to monitor organ function and the accumulation of immune cells at a transplanted organ. One of the center's primary goals is to establish a non-invasive, reliable and sensitive technique that not only detects acute rejection, but also correctly identifies rejection grades. With further development, such technology should help physicians detect organ rejection at early stages and also improve a patient's quality of life by reducing the number of invasive, post-transplantation tissue biopsies.
  • In-Vivo Magnetic Resonance Microscopy. Tracking the initiation and progression of autoimmune diseases such as multiple sclerosis (MS) is extremely difficult using current imaging technologies. NMR Center scientists are maki
    '"/>


Contact: Lauren Ward
wardle@andrew.cmu.edu
412-268-7761
Carnegie Mellon University
15-Mar-2004


Page: 1 2 3

Related biology news :

1. University of Pittsburgh receives $10 million grant for head and neck cancer
2. University of Pittsburgh medical center among first to implant heart assist device
3. University of Pittsburgh receives NIH funding to develop heart assist device for infants
4. University of Pittsburgh Medical Center acquires biotechnology firm Rheogene Inc.
5. Pittsburgh researchers engineer and successfully test SARS corona vaccine in animal model
6. Protein biomarkers accurately and quickly diagnose ALS, find Pittsburgh researchers
7. University of Pittsburgh scientist honored for major accomplishment in cancer research
8. Worlds largest scientific society to hold regional meeting in Pittsburgh
9. University of Pittsburgh named cooperative research center for muscular dystrophy
10. Infectious disease study findings presented by University of Pittsburgh scientists
11. University of Pittsburgh study links gynecological complaint to increased risk for herpes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/19/2020)... FARMINGTON, Conn. (PRWEB) , ... March 17, 2020 ... ... that develops tools for characterizing microbiome populations down to the strain level, recently ... , The Shoreline Wave amplicon kit contains the same innovative amplification capabilities as ...
(Date:3/13/2020)... ... March 13, 2020 , ... Acumed LLC today announced that ... distributor of the Louisville-based company’s orthobiologics portfolio. Under the terms of the agreement, ... calcium phosphate-based bone allograft (Trabexus) and calcium phosphate-based biocement (Fortera). Vivorte will continue ...
(Date:3/9/2020)... ... March 09, 2020 , ... ... steep growth rate of 64% last year, as enterprises sought to achieve ... Everest Group. Unfortunately, only 13% of all transformation efforts delivered the intended ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... ... process solutions for the life sciences industry, today announced the opening of a ... Nagamura, Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new office ...
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced it is now registering ... Las Vegas. The course is hands on involving real patients and stem cell biologics, ... the Comprehensive Stem Cell Training Course has received rave reviews from attendees, who love ...
(Date:2/3/2020)... Mass. (PRWEB) , ... February 03, 2020 , ... ... US offices in Cambridge, MA, announce that OmniType, the 11-locus, single tube multiplex ... today. OmniType is a best-in-class product featuring locus-multiplexing and short library preparation, for ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, the leader in ... computing, today announced the availability of neuroscience of transformational leadership workshops. These highly ... neuroscience of leadership and change research to become great transformational leaders. The ...
Breaking Biology Technology:
Cached News: